The companion diagnostic was once a niche sidekick in oncology, a modest tool for identifying the right patients for a small ...
Dr Daniel Petrylak discusses groundbreaking advancements in prostate cancer treatment, including genetic mutations, PARP ...
Researchers from the University of Birmingham's Bladder Cancer Research Center have used a new method to detect chemical ...
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...
According to Kadam, scientific and technological advancements in genomics over the past decade have driven affordability and ...
“GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation,” said Sumir Bhatia, President, Lenovo ISG Asia Pacific. “With this leap in performance and ...
The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven ...
The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers.Eight years after the first CAR-T product entered the market, members ...
So welcome to our Pharma Day 2025 here in London. It's good to see here full house. I was told we have, I think, a record attendance here on site, and we also have quite a high number, I think, of web ...
The volatile biotech industry has done reasonably well so far in 2025 amid the ongoing tariff saga. Most pharma/biotech bigwigs are now investing heavily in manufacturing plants/operations in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results